These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3799149)

  • 1. Urinary unconjugated cortisol in normally menstruating women and during estrogen-gestagen treatment.
    Felding C; Mikkelsen AL; Birch CD
    Acta Obstet Gynecol Scand; 1986; 65(6):547-50. PubMed ID: 3799149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives.
    Kojima T; Lindheim SR; Duffy DM; Vijod MA; Stanczyk FZ; Lobo RA
    Am J Obstet Gynecol; 1993 Dec; 169(6):1540-4. PubMed ID: 8267059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical experience with two low dosage estrogen progestogen preparations (SH 7.1122 and SH B 259 AB)].
    Leone U; Di Girolamo V
    Minerva Ginecol; 1980 Sep; 32(9):791-800. PubMed ID: 7012684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M; Kitchens CS; Khan FY
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of the effect of oral contraceptives containing 50 microgram of estrogen and those containing 20 microgram of estrogen on adrenal cortical function.
    Amin ES; El-Sayed MM; El-Gamel BA; Nayel SA
    Am J Obstet Gynecol; 1980 Aug; 137(7):831-3. PubMed ID: 7405974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two oral contraceptives with the same gestagen and different estrogen. A controlled clinical trial.
    Flodgaard D; Helles A; Jacobsen M
    Contraception; 1975 Jul; 12(1):77-88. PubMed ID: 1095298
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in insulin receptors during oral contraception.
    De Pirro R; Forte F; Bertoli A; Greco AV; Lauro R
    J Clin Endocrinol Metab; 1981 Jan; 52(1):29-33. PubMed ID: 7451643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenocortical function of patients using oral contraceptives.
    Kauppila A; Järvinen PA; Ylöstalo P; Reinilä M
    Acta Obstet Gynecol Scand; 1974; 53(2):155-9. PubMed ID: 4362662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenocortical function studies during the normal menstrual cycle and in women receiving norethindrone with and without mestranol.
    Beck RP; Morcos F; Fawcett D; Watanabe M
    Am J Obstet Gynecol; 1972 Feb; 112(3):364-8. PubMed ID: 5060381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of sex, age, synthetic oestrogens, progestogens and oral contraceptives on the excretion of urinary tryptophan metabolites.
    Moursi GE; Abdel-Daim MH; Kelada NL; Abdel-Tawab GA; Girgis LH
    Bull World Health Organ; 1970; 43(5):651-61. PubMed ID: 5313362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleeding patterns with monophasic and triphasic low-dose ethinyl estradiol combined oral contraceptives.
    Hampton RM; Zhang HF; Barnowski C; Wan GJ
    Contraception; 2008 Jun; 77(6):415-9. PubMed ID: 18477490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of oral contraceptives on plasma cortisol and cortisol binding capacity throughout the menstrual cycle in normal women.
    Durber SM; Lawson J; Daly JR
    Br J Obstet Gynaecol; 1976 Oct; 83(10):814-8. PubMed ID: 791349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the clinical performance of three triphasic oral contraceptives: a multicenter, randomized comparative trial.
    Schilling LH; Bolding OT; Chenault CB; Chong AP; Fleury F; Forrest K; Glick HI; Hasson HM; Heil CG; London RS
    Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1264-8. PubMed ID: 2655451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum tsh and serum t3 levels during normal menstrual cycles and during cycles on oral contraceptives.
    Weeke J; Hansen AP
    Acta Endocrinol (Copenh); 1975 Jul; 79(3):431-8. PubMed ID: 1173500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and biological justifications for the use of Triella].
    McGuire JL; Pasquale SA; Castaigne JP
    Rev Fr Gynecol Obstet; 1986 Dec; 81(12):731-6. PubMed ID: 3823727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of hormonal contraceptives on menstrual and reproductive function of women].
    Dubnitskaia LV; Sotnikova EI
    Akush Ginekol (Mosk); 1990 Apr; (4):57-60. PubMed ID: 1696071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy.
    Rosenfeld WE; Doose DR; Walker SA; Nayak RK
    Epilepsia; 1997 Mar; 38(3):317-23. PubMed ID: 9070594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reference period analysis of vaginal bleeding with triphasic oral contraceptive agents containing norethindrone or levonorgestrel: a comparison study.
    Schwarz BE; Pierce C; Walden CE; Knopp RH
    Int J Fertil; 1992; 37(3):176-82. PubMed ID: 1355765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.